Table 3 AE count and disability for each fluoroquinolone (counts)a
From: Evaluation of disability in patients exposed to fluoroquinolones
1 confirmed qualifying AE | 1 confirmed qualifying AE + Disability | 2+ confirmed qualifying AEs | 2 + confirmed qualifying AEs + Disability | ||
|---|---|---|---|---|---|
Count Used for Any Condition | Count (Row %) | ||||
Levofloxacin | 49,923 | 7559 (15.1%) | 472 (0.9%) | 1328 (2.7%) | 117 (0.2%) |
Ciprofloxacin | 56,792 | 7062 (12.4) | 530 (0.9) | 1109 (2.0) | 111 (0.2) |
Moxifloxacin | 12,117 | 1863 (15.4) | 105 (0.9) | 281 (2.3) | 34 (0.3) |
Ofloxacin | 52 | 6 (11.5) | 0 (0.0) | 1 (1.9) | 0 (0.0) |
Gemifloxacin | 785 | 110 (14.0) | 5 (0.6) | 16 (2.0) | 2 (0.3) |
Gatifloxacin | 2 | 0 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Norfloxacin | 5 | 0 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
TOTAL | 119,676 | 16,600 | 1112 | 2735 | 264 |